EPISODE · Jun 14, 2024 · 9 MIN
Davern Capital sees GLP-1 Opportunities Beyond Obesity
Davern Capital’s founder, Elie Kobrin, approaches the biopharma market from a long/short perspective – but as a former doctor, he also speaks the language of medicine. He explains the fund’s approach and offers insights on hot topics in the current market.
Embed this episode
NOW PLAYING
Davern Capital sees GLP-1 Opportunities Beyond Obesity
0:00
9:39
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 9 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on June 14, 2024.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!